113 related articles for article (PubMed ID: 24260583)
1. Targeting eukaryotic translation in mesothelioma cells with an eIF4E-specific antisense oligonucleotide.
Jacobson BA; Thumma SC; Jay-Dixon J; Patel MR; Dubear Kroening K; Kratzke MG; Etchison RG; Konicek BW; Graff JR; Kratzke RA
PLoS One; 2013; 8(11):e81669. PubMed ID: 24260583
[TBL] [Abstract][Full Text] [Related]
2. Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma.
Jacobson BA; De A; Kratzke MG; Patel MR; Jay-Dixon J; Whitson BA; Sadiq AA; Bitterman PB; Polunovsky VA; Kratzke RA
Br J Cancer; 2009 Aug; 101(3):424-31. PubMed ID: 19603014
[TBL] [Abstract][Full Text] [Related]
3. Computational inference of eIF4F complex function and structure in human cancers.
Wu S; Wagner G
Proc Natl Acad Sci U S A; 2024 Jan; 121(5):e2313589121. PubMed ID: 38266053
[TBL] [Abstract][Full Text] [Related]
4. 4Ei-10 interdiction of oncogenic cap-mediated translation as therapy for non-small cell lung cancer.
Jacobson BA; Ahmad Z; Chen S; Waldusky G; Dillenburg M; Stoian E; Cambron DA; Patel AJ; Patel MR; Wagner CR; Kratzke RA
Invest New Drugs; 2021 Jun; 39(3):636-643. PubMed ID: 33230623
[TBL] [Abstract][Full Text] [Related]
5. Differential Regulation of the Melanoma Proteome by eIF4A1 and eIF4E.
Joyce CE; Yanez AG; Mori A; Yoda A; Carroll JS; Novina CD
Cancer Res; 2017 Feb; 77(3):613-622. PubMed ID: 27879264
[TBL] [Abstract][Full Text] [Related]
6. La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs.
Lahr RM; Fonseca BD; Ciotti GE; Al-Ashtal HA; Jia JJ; Niklaus MR; Blagden SP; Alain T; Berman AJ
Elife; 2017 Apr; 6():. PubMed ID: 28379136
[TBL] [Abstract][Full Text] [Related]
7. Computational inference of eIF4F complex function and structure in human cancers.
Wu S; Wagner G
bioRxiv; 2023 Aug; ():. PubMed ID: 37609226
[TBL] [Abstract][Full Text] [Related]
8. Identification of a First-in-Class Small-Molecule Inhibitor of the EIF4E-RBM38 Complex That Enhances Wild-type TP53 Protein Translation for Tumor Growth Suppression.
Lucchesi CA; Zhang J; Gao M; Shaw J; Chen X
Mol Cancer Ther; 2023 Jun; 22(6):726-736. PubMed ID: 36940176
[TBL] [Abstract][Full Text] [Related]
9. RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site.
George J; Li Y; Kadamberi IP; Parashar D; Tsaih SW; Gupta P; Geethadevi A; Chen C; Ghosh C; Sun Y; Mittal S; Ramchandran R; Rui H; Lopez-Berestein G; Rodriguez-Aguayo C; Leone G; Rader JS; Sood AK; Dey M; Pradeep S; Chaluvally-Raghavan P
Cell Rep; 2021 Nov; 37(5):109934. PubMed ID: 34731628
[TBL] [Abstract][Full Text] [Related]
10. Developing anti-neoplastic biotherapeutics against eIF4F.
Steinberger J; Chu J; Maïga RI; Sleiman K; Pelletier J
Cell Mol Life Sci; 2017 May; 74(9):1681-1692. PubMed ID: 28004147
[TBL] [Abstract][Full Text] [Related]
11. Revealing molecular pathways for cancer cell fitness through a genetic screen of the cancer translatome.
Kuzuoglu-Ozturk D; Hu Z; Rama M; Devericks E; Weiss J; Chiang GG; Worland ST; Brenner SE; Goodarzi H; Gilbert LA; Ruggero D
Cell Rep; 2021 Jun; 35(13):109321. PubMed ID: 34192540
[TBL] [Abstract][Full Text] [Related]
12. Assessing eukaryotic initiation factor 4F subunit essentiality by CRISPR-induced gene ablation in the mouse.
Sénéchal P; Robert F; Cencic R; Yanagiya A; Chu J; Sonenberg N; Paquet M; Pelletier J
Cell Mol Life Sci; 2021 Oct; 78(19-20):6709-6719. PubMed ID: 34559254
[TBL] [Abstract][Full Text] [Related]
13. Targeting eukaryotic protein translation in mesothelioma.
Kratzke RA
Transl Lung Cancer Res; 2017 Jun; 6(3):343-349. PubMed ID: 28713679
[TBL] [Abstract][Full Text] [Related]
14. Suppression of eukaryotic initiation factor 4E prevents chemotherapy-induced alopecia.
Nasr Z; Dow LE; Paquet M; Chu J; Ravindar K; Somaiah R; Deslongchamps P; Porco JA; Lowe SW; Pelletier J
BMC Pharmacol Toxicol; 2013 Nov; 14():58. PubMed ID: 24219888
[TBL] [Abstract][Full Text] [Related]
15. Nontoxic chemical interdiction of the epithelial-to-mesenchymal transition by targeting cap-dependent translation.
Ghosh B; Benyumov AO; Ghosh P; Jia Y; Avdulov S; Dahlberg PS; Peterson M; Smith K; Polunovsky VA; Bitterman PB; Wagner CR
ACS Chem Biol; 2009 May; 4(5):367-77. PubMed ID: 19351181
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL.
Largeot A; Klapp V; Viry E; Gonder S; Fernandez Botana I; Blomme A; Benzarti M; Pierson S; Duculty C; Marttila P; Wierz M; Gargiulo E; Pagano G; An N; El Hachem N; Perez Hernandez D; Chakraborty S; Ysebaert L; François JH; Cortez Clemente S; Berchem G; Efremov DG; Dittmar G; Szpakowska M; Chevigné A; Nazarov PV; Helleday T; Close P; Meiser J; Stamatopoulos B; Désaubry L; Paggetti J; Moussay E
Blood; 2023 Jun; 141(26):3166-3183. PubMed ID: 37084385
[TBL] [Abstract][Full Text] [Related]
17. Theranostic DNA nanostructure based on phenotype-specific activation of antisense oligonucleotides.
Chu LT; Kwong HK; Cui C; Chen TH
Talanta; 2024 Mar; 269():125399. PubMed ID: 37979506
[TBL] [Abstract][Full Text] [Related]
18. The role of the 5' untranslated region of eukaryotic messenger RNAs in translation and its investigation using antisense technologies.
Pantopoulos K; Johansson HE; Hentze MW
Prog Nucleic Acid Res Mol Biol; 1994; 48():181-238. PubMed ID: 7938549
[TBL] [Abstract][Full Text] [Related]
19. Cellular delivery of dinucleotides by conjugation with small molecules: targeting translation initiation for anticancer applications.
Kleczewska N; Sikorski PJ; Warminska Z; Markiewicz L; Kasprzyk R; Baran N; Kwapiszewska K; Karpinska A; Michalski J; Holyst R; Kowalska J; Jemielity J
Chem Sci; 2021 Aug; 12(30):10242-10251. PubMed ID: 34377411
[TBL] [Abstract][Full Text] [Related]
20. The Synergistic Effect of N2 and N7 Modifications on the Inhibitory Efficacy of mRNA Cap Analogues.
Kurpiejewski K; Piecyk K; Lukaszewicz M; Kamel K; Chmurski K; Kmiecik S; Jankowska-Anyszka M
Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
